PharmaTimes https://pharmatimes.com in-depth news, features and insights for the pharmaceutical and healthcare sectors Sun, 09 Aug 2026 17:38:56 +0000 en-US hourly 1 https://pharmatimes.com/wp-content/uploads/2023/11/PT-icon-150x150.png PharmaTimes https://pharmatimes.com 32 32 232894315 Entera Bio data selected for ASBMR plenary session https://pharmatimes.com/news/entera-bio-data-selected-for-asbmr-plenary-session/ Thu, 06 Aug 2026 22:02:00 +0000 https://pharmatimes.com/?p=104891 Postmenopausal study highlights oral anabolic potential

]]> 104891 NHS backs delayed‑release treatment for cystinosis https://pharmatimes.com/news/nhs-backs-delayed-release-treatment-for-cystinosis/ Wed, 05 Aug 2026 22:30:00 +0000 https://pharmatimes.com/?p=104893 Decision expands options for eligible patients

]]> 104893 Oblenio doses first patients in phase 1a autoimmune trial https://pharmatimes.com/news/oblenio-doses-first-patients-in-phase-1a-autoimmune-trial/ Wed, 05 Aug 2026 10:33:53 +0000 https://pharmatimes.com/?p=104889 Study evaluates tri‑specific T cell engager LBL‑051

]]> 104889 BeOne Medicines secures UK innovation passport for HCC therapy https://pharmatimes.com/news/beone-medicines-secures-uk-innovation-passport-for-hcc-therapy/ Wed, 05 Aug 2026 09:59:35 +0000 https://pharmatimes.com/?p=104887 Designation supports accelerated access for investigational antibody

]]> 104887 Sanofi’s MenQuadfi approved for EU infants https://pharmatimes.com/news/sanofis-menquadfi-approved-for-eu-infants/ Tue, 04 Aug 2026 11:18:01 +0000 https://pharmatimes.com/?p=104884 EC expands use to protect youngest children

]]> 104884 Qnovia licenses novel antimicrobial peptide https://pharmatimes.com/news/qnovia-licenses-novel-antimicrobial-peptide/ Tue, 04 Aug 2026 11:03:57 +0000 https://pharmatimes.com/?p=104879 New therapy aims to tackle antibiotic resistance

]]> 104879 Lexeo wins FDA RMAT status for LX2020 https://pharmatimes.com/news/lexeo-wins-fda-rmat-status-for-lx2020/ Mon, 03 Aug 2026 22:32:00 +0000 https://pharmatimes.com/?p=104901 Regulator backs gene therapy for PKP2-ACM

]]> 104901 Polpharma Biologics gains FDA and EMA review acceptances https://pharmatimes.com/news/polpharma-biologics-gains-fda-and-ema-review-acceptances/ Mon, 03 Aug 2026 11:03:33 +0000 https://pharmatimes.com/?p=104874 Regulators assess PB016 vedolizumab biosimilar applications

]]> 104874 Parsortix study shows promise for ADC target detection https://pharmatimes.com/news/parsortix-study-shows-promise-for-adc-target-detection/ Mon, 03 Aug 2026 10:54:03 +0000 https://pharmatimes.com/?p=104872 Researchers highlight minimally invasive monitoring potential

]]> 104872 Vista trial begins dosing in precision cancer vaccine study https://pharmatimes.com/news/vista-trial-begins-dosing-in-precision-cancer-vaccine-study/ Thu, 30 Jul 2026 11:09:44 +0000 https://pharmatimes.com/?p=104869 First-in-human evaluation of infinitopes’ therapeutic platform

]]> 104869